Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC welcomes Health Economist Agni Baka to the team

15 May 2023

We are happy to announce a further expansion of our HEOR Department with Agni Baka, a health economist from the Netherlands.

Agni holds a Master's Degree in Health Economics from the Erasmus University Rotterdam (2013), and she is a PhD Candidate (2023) from the Vrije Universiteit Amsterdam in the Netherlands.

Agni has six years of experience in the field of health economics and European health technology assessment (HTA). Agni combines expertise from both consultancy (Mapi Group in the Netherlands) and academia (Vrije Universiteit Amsterdam).

Agni was involved in health economic research of non-pharmaceutical health interventions in the Netherlands and had a number of health economic publications in peer-reviewed journals (Applied Health Economics and Health Policy, Behavioral Sleep Medicine, International Journal of Behavioral Nutrition and Physical Activity).

If you are interested in learning about our capabilities with health economic analysis and evidence synthesis, please, reach out to us to arrange a call to discuss your needs.